State Street’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History
Bought
Maintained
Sold
Other funds holding NBP
HA
SL
ACM
CS
WP
State Street's NBP Position: Q1 2026 in Review
State Street increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 2.8% in Q1 2026, buying an estimated $34.2K and bringing the position to 370,107 shares worth $910K. The position accounts for ﹤0.01% of the portfolio, ranked #3509.
State Street first reported a position in NBP in Q4 2020 and has held it in 18 quarters since. The position peaked at $39.7M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.
- State Street held 370,107 shares of NovaBridge Biosciences American Depositary Shares worth $910K as of Q1 2026.
- State Street bought 10,229 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $34.2K.
- NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3509 holding.
- State Street first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 18 quarters since.
- State Street's NovaBridge Biosciences American Depositary Shares position peaked at $39.7M in Q3 2021.
- 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.